Enhanced Genomics
PrivateLast Round
Series A
Oct 20, 2022
Est. Valuation
$31.18M
Total Funding Raised
$21.41M
Company Overview
Enhanced Genomics is a biotechnology company that develops a 3D multi-omics platform to map genome folding and identify therapeutic targets for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enhanced Genomics Comparables
Compare Enhanced Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleome Therapeutics | 87% | |
| Genomics | 77% | |
| Arima Genomics | 77% | |
Enhanced Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 20, 2022 | ||||
| Seed | Mar 26, 2021 |
Key People
Founding team and executive leadership
Enhanced Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start Codon | Seed |
| BGF | Series A |
| Meltwind Advisory | Series A |
| Bioqube Ventures | Series A, Seed |
| Parkwalk Advisors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
Monthly visitors increased 280% MoM to 3.2K.
Enhanced Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enhanced Genomics's valuation, stock price, and market status.